Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nader Moazami

Showing results (131-140 of 192) with videos related to

Pageof 20
Sort By:
JTCVS Open|March 10, 2025
Decreased bleeding and thrombotic complications on extracorporeal membrane oxygenation support following an updated anticoagulation protocolMichael Dorsey, Katherine Phillips, Les James, et al.
Frontiers in Medicine|January 6, 2022
CytoSorb Therapy in COVID-19 (CTC) Patients Requiring Extracorporeal Membrane Oxygenation: A Multicenter, Retrospective RegistryTae Song, Jeremiah Hayanga, Lucian Durham, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|August 12, 2021
Safety and Feasibility of an Early Mobilization Protocol for Patients with Femoral Intra-Aortic Balloon Pumps as Bridge to Heart TransplantStacey Chen, Lynette Lester, Greta L Piper, et al.
The Annals of Thoracic Surgery|December 25, 2012
Pump replacement for left ventricular assist device failure can be done safely and is associated with low mortalityNader Moazami, Carmelo A Milano, Ranjit John, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|June 9, 2018
Utility of the Psychosocial Assessment of Candidates for Transplantation in Patients Undergoing Continuous-Flow Left Ventricular Assist Device ImplantationMeghana Halkar, Amy S Nowacki, Kay Kendall, et al.
Journal of Molecular and Cellular Cardiology|May 19, 2011
Effects of KATP channel openers diazoxide and pinacidil in coronary-perfused atria and ventricles from failing and non-failing human heartsVadim V Fedorov, Alexey V Glukhov, Christina M Ambrosi, et al.
Clinical Transplantation|May 23, 2020
Outcomes of the Treatment with Glecaprevir/Pibrentasvir following heart transplantation utilizing hepatitis C viremic donorsAlex Reyentovich, Claudia G Gidea, Deane Smith, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 1, 2009
Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulationAndrew J Boyle, Stuart D Russell, Jeffrey J Teuteberg, et al.
Clinical Transplantation|June 9, 2022
Pre-transplant immune cell function assay as a predictor of early cardiac allograft rejectionSamuel D Maidman, Claudia Gidea, Alex Reyentovich, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 16, 2015
First report of 90-day support of 2 calves with a continuous-flow total artificial heartJamshid H Karimov, Nader Moazami, Mariko Kobayashi, et al.
Pageof 20

Showing results (131-140 of 192) with videos related to

Sort By:
Pageof 20
JTCVS Open|March 10, 2025
Decreased bleeding and thrombotic complications on extracorporeal membrane oxygenation support following an updated anticoagulation protocolMichael Dorsey, Katherine Phillips, Les James, et al.
Frontiers in Medicine|January 6, 2022
CytoSorb Therapy in COVID-19 (CTC) Patients Requiring Extracorporeal Membrane Oxygenation: A Multicenter, Retrospective RegistryTae Song, Jeremiah Hayanga, Lucian Durham, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|August 12, 2021
Safety and Feasibility of an Early Mobilization Protocol for Patients with Femoral Intra-Aortic Balloon Pumps as Bridge to Heart TransplantStacey Chen, Lynette Lester, Greta L Piper, et al.
The Annals of Thoracic Surgery|December 25, 2012
Pump replacement for left ventricular assist device failure can be done safely and is associated with low mortalityNader Moazami, Carmelo A Milano, Ranjit John, et al.
Progress in Transplantation (Aliso Viejo, Calif.)|June 9, 2018
Utility of the Psychosocial Assessment of Candidates for Transplantation in Patients Undergoing Continuous-Flow Left Ventricular Assist Device ImplantationMeghana Halkar, Amy S Nowacki, Kay Kendall, et al.
Journal of Molecular and Cellular Cardiology|May 19, 2011
Effects of KATP channel openers diazoxide and pinacidil in coronary-perfused atria and ventricles from failing and non-failing human heartsVadim V Fedorov, Alexey V Glukhov, Christina M Ambrosi, et al.
Clinical Transplantation|May 23, 2020
Outcomes of the Treatment with Glecaprevir/Pibrentasvir following heart transplantation utilizing hepatitis C viremic donorsAlex Reyentovich, Claudia G Gidea, Deane Smith, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 1, 2009
Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulationAndrew J Boyle, Stuart D Russell, Jeffrey J Teuteberg, et al.
Clinical Transplantation|June 9, 2022
Pre-transplant immune cell function assay as a predictor of early cardiac allograft rejectionSamuel D Maidman, Claudia Gidea, Alex Reyentovich, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 16, 2015
First report of 90-day support of 2 calves with a continuous-flow total artificial heartJamshid H Karimov, Nader Moazami, Mariko Kobayashi, et al.
Pageof 20